Status:

NOT_YET_RECRUITING

Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples

Lead Sponsor:

Kırıkkale University

Conditions:

Pulpitis

Pulpitis - Irreversible

Eligibility:

All Genders

18-64 years

Brief Summary

This study aimed to compare the changes in AQP -4, -5, -9, and IL-8 levels in pulp tissue, GCF, and dentin fluid samples routinely obtained during the treatment of healthy and symptomatic teeth diagno...

Detailed Description

A total of 70 healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) patients aged 18-64 years, who will undergo routine root canal treatment at Kırıkkale University, Faculty of Dentistry, ...

Eligibility Criteria

Inclusion

  • Patients aged 18 to 64 years.
  • Patients without any known systemic disease.
  • Patients requiring root canal treatment for prosthetic purposes (Healthy pulp group).
  • Patients with third molars (wisdom teeth) indicated for extraction due to orthodontic or other clinical reasons (Healthy pulp group).
  • Patients diagnosed with symptomatic irreversible pulpitis based on the criteria established by the American Association of Endodontists (AAE) (Symptomatic irreversible pulpitis group).
  • Patients scheduled for routine root canal treatment at the Department of Endodontics, Faculty of Dentistry, Kırıkkale University.
  • Patients who have provided written informed consent to participate in the study.

Exclusion

  • Patients with any known systemic disease.
  • Pregnant women or those suspected of being pregnant.
  • Patients who have used antibiotics, anti-inflammatory drugs, or antidepressants within the past 4 weeks.
  • Patients with significant dental plaque or calculus, gingival redness or bleeding, severe gingivitis, generalized periodontitis, or periodontal pockets deeper than 4 mm.
  • Patients with teeth showing internal or external root resorption.
  • Patients for whom complete rubber dam isolation cannot be achieved.
  • Patients with teeth exhibiting signs of necrosis, apical lesions, swelling, or presence of a sinus tract.
  • Patients with immature teeth presenting open apices.
  • Patients with third molars (wisdom teeth) that are not fully erupted or have been previously diagnosed with pericoronitis.

Key Trial Info

Start Date :

December 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 12 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06938191

Start Date

December 1 2025

End Date

September 12 2026

Last Update

December 1 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.